We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Lung CT Scans of COVID-19 Patients Can Predict Neurological Problems Revealed Later by Brain MRIs

By HospiMedica International staff writers
Posted on 15 Mar 2021
Image: Achala Vagal, MD, author on the study, reviews an MRI scan (Photo courtesy of Colleen Kelley)
Image: Achala Vagal, MD, author on the study, reviews an MRI scan (Photo courtesy of Colleen Kelley)
For the first time, a multicenter study has found a visual correlation between the severity of the disease in the lungs using CT scans and the severity of effects on patient’s brains, using MRI scans.

The results of the study led by University of Cincinnati (Cincinnati, OH, USA) show that by looking at lung CT scans of patients diagnosed with COVID-19, physicians may be able to predict just how badly they can experience other neurological problems that could show up on brain MRIs, helping improve patient outcomes and identify symptoms for earlier treatment. CT imaging can detect illness in the lungs better than an MRI, another medical imaging technique. However, MRI can detect many problems in the brain, particularly in COVID-19 patients, that cannot be detected on CT images.

In the study, researchers reviewed electronic medical records and images of hospitalized COVID-19 patients. Patients who were diagnosed with COVID-19, experienced neurological issues and who had both lung and brain images available were included. Out of 135 COVID-19 patients with abnormal CT lung scans and neurological symptoms, 49, or 36%, were also found to develop abnormal brain scans and were more likely to experience stroke symptoms.

The researchers believe that the study will help physicians classify patients, based on the severity of disease found on their CT scans, into groups more likely to develop brain imaging abnormalities. Additionally, the correlation could be important for implementing therapies, particularly in stroke prevention, to improve outcomes in patients with COVID-19.

“These results are important because they further show that severe lung disease from COVID-19 could mean serious brain complications, and we have the imaging to help prove it,” said Abdelkader Mahammedi, MD, assistant professor of radiology, UC Health radiologist and member of the UC Gardner Neuroscience Institute. “Future larger studies are needed to help us understand the tie better, but for now, we hope these results can be used to help predict care and ensure that patients have the best outcomes.”

Related Links:
University of Cincinnati

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Electrically Operated Patient Lifter
SVL 205
New
Patient Monitor
IntelliVue MP5SC

Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more